Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Metastatic hepatocellular carcinoma.

S Kummar1, N Q Shafi

  • 1Department of Medicine, Yale Cancer Center, Yale University School of Medicine and VA Connecticut Cancer Center, VA Connecticut Healthcare System, West Haven, CT 06516, USA. kummars@yahoo.com

Clinical Oncology (Royal College of Radiologists (Great Britain))
|August 20, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The ESMO Tumour-Agnostic Classifier and Screener (ETAC-S): a tool for assessing tumour-agnostic potential of molecularly guided therapies and for steering drug development.

Annals of oncology : official journal of the European Society for Medical Oncology·2024
Same author

First-in-human phase 0 study of <sup>111</sup>In-CHX-A"-DTPA trastuzumab for HER2 tumor imaging.

Journal of translational science·2019
Same author

Utility of <sup>18</sup>F-fluoroestradiol (<sup>18</sup>F-FES) PET/CT imaging as a pharmacodynamic marker in patients with refractory estrogen receptor-positive solid tumors receiving Z-endoxifen therapy.

European journal of nuclear medicine and molecular imaging·2016
Same author

Cytokeratin staining for primary and metastatic colorectal cancer.

Clinical colorectal cancer·2002
Same author

Positron emission tomography for the evaluation of patients with colorectal cancer.

Clinical colorectal cancer·2002
Same author

Cytokeratin 7 and 20 staining for the diagnosis of lung and colorectal adenocarcinoma.

British journal of cancer·2002

Hepatocellular carcinoma (HCC), a common cancer, often spreads to distant sites like the skull. This review highlights metastatic HCC pathology, staging, and treatment challenges for better patient outcomes.

Area of Science:

  • Oncology
  • Pathology

Background:

  • Hepatocellular carcinoma (HCC) is a prevalent global cancer, particularly in areas with high rates of chronic viral hepatitis B infection.
  • Metastatic HCC frequently spreads to organs such as the lungs, lymph nodes, adrenal glands, and bones, including the skull.

Observation:

  • This review details a case report on metastatic HCC, emphasizing its unique pathological characteristics.
  • It also provides a concise overview of the pathological features, staging systems, therapeutic options, and prognostic factors associated with metastatic HCC.

Findings:

  • Metastatic HCC presents distinct pathological features that are crucial for diagnosis and understanding disease progression.
  • Current staging criteria and prognostic indicators are vital for patient stratification in clinical trials.

Related Experiment Videos

Implications:

  • Further randomized clinical trials are essential to evaluate novel treatment strategies for metastatic HCC.
  • Accurate pathological assessment and staging are critical for improving the poor prognosis associated with advanced HCC.